Skip to main content
Clinical Trials/NCT05085821
NCT05085821
Completed
N/A

Cardio-visual Stimulation in Augmented Reality for Pain Reduction

Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est1 site in 1 country32 target enrollmentApril 20, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Regional Pain Syndrome
Sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Enrollment
32
Locations
1
Primary Endpoint
Change in perceived pain
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of this study is to evaluate the feasibility and efficacy of an Augmented Reality (AR) biofeedback intervention to alleviate pain symptoms in individuals suffering from chronic pain of the hand and/or the forearm.

Detailed Description

Chronic pain is a major public health problem with implications for high health care costs, lost productivity and an estimated financial burden of $500 billion. Individuals with chronic pain are also at an increased risk of developing an opioid use disorder. Chronic pain has previously been associated with a distorted body representation, in particular of the affected body parts. Virtual Reality (VR) studies using embodiment-, respiration-, and heart-beat related feedback have demonstrated positive effects for induced pain in healthy participants (e.g., increased pain thresholds) and chronic pain in patient populations (e.g., decreased subjective pain, improved functionality, improved physiological markers of pain). Based on these studies, the AR intervention evaluated here aims to alleviate subjective pain symptoms and improve physiological pain markers in chronic pain patients using heartbeat-related feedback. This within-subject study will compare subjective pain ratings before, during, and after an AR intervention that provides visual feedback of participants' on-going heartbeat in relation to their affected limb. Primary outcomes include subjective reports from participants (perceived efficacy, acceptability, and demand) and the intervention's clinical feasibility, including reports from therapists. Secondary outcomes include changes in heart rate and variability.

Registry
clinicaltrials.gov
Start Date
April 20, 2021
End Date
June 29, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Responsible Party
Principal Investigator
Principal Investigator

Amélie Touillet

Principal Investigator

Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

Eligibility Criteria

Inclusion Criteria

  • Be over 18 years of age
  • Present permanent chronic pain (for more than 3 months), secondary to a peripheral pathology (traumatic, orthopedic or neurological), located in the hand or forearm.

Exclusion Criteria

  • Pregnant women
  • People in emergency situations
  • Persons unable to give informed consent
  • Persons who are mentally or linguistically unable to understand the research test instructions
  • Individuals who are not available to complete the entire study protocol
  • Cognitive impairments that prevent the use of the equipment
  • Psychiatric disorders
  • Patients with seizure disorders
  • Patients with central hemineglect
  • Pain secondary to central nervous system pathology

Outcomes

Primary Outcomes

Change in perceived pain

Time Frame: change in pain rating will be evaluated when participants first wear the Head-Mounted Display (baseline), after 3 minutes of video-passthrough (Pre), after 3 minutes of cardio-visual stimulation (post), after 3 minutes of video-passthrough (final)

The patient moves a cursor on a Visual Analog Scale to indicate their currently perceived level of pain. The gauge ranges from "no pain" (0) to "worst pain imaginable" (10).

Change in Heart-Rate Variability (frequency domain)

Time Frame: a change in heart-rate variability will be evaluated between baseline (pre), intervention, and immediately following intervention (post)

frequency-domain metric of heart-rate variability (power)

Change in Heart-Rate Variability (time domain)

Time Frame: a change in heart-rate variability will be evaluated between baseline (pre), intervention, and immediately following intervention (post)

time-domain metrics of heart-rate variability \[ms\]

Secondary Outcomes

  • Questionnaire(The fourth day of the study)

Study Sites (1)

Loading locations...

Similar Trials